Second Hepatic Resection for Recurrent Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

Kubo, Shoji; Takemura, Shigekazu; Uenishi, Takahiro; Yamamoto, Takatsugu; Ohba, Kazuki; Ogawa, Masao; Hai, Seikan; Ichikawa, Tsuyoshi; Kodai, Shintaro; Shinkawa, Hiroji; Tanaka, Hiromu
April 2008
World Journal of Surgery;Apr2008, Vol. 32 Issue 4, p632
Academic Journal
Although a second hepatic resection (SHR) for recurrent hepatocellular carcinoma (HCC) is widely accepted, the indications for SHR have not been established. The risk factors for HCC recurrence after SHR were evaluated to investigate the indications for SHR. Subjects included 51 patients who underwent a second hepatic resection for recurrence of HCV-related HCC. Sixteen patients received interferon therapy before or after the first operation. Six patients attained a sustained viral response (SVR) that was defined as return of the alanine aminotransferase (ALT) activity to within the reference range and no detectable serum HCV RNA for at least 1 year after interferon therapy. A biochemical response (BR), defined as a normalized ALT activity for at least 1 year after interferon therapy with or without the transient disappearance of serum HCV RNA, was attained in three patients. The other seven patients were defined as the nonresponse (NR) group. By univariate analysis, NR and lack of interferon therapy, high indocyanine green retention rate at 15 min (ICGR15), high aspartate aminotransferase activity, high ALT activity, large tumor, and multiple tumors were risk factors for HCC recurrence after SHR. By multivariate analysis, NR and lack of interferon therapy, high ICGR15, large tumor, and multiple tumors were independent risk factors. Patients in whom active hepatitis has been controlled by interferon therapy are the best candidates for SHR. Interferon therapy should be recommended in patients undergoing resection of an HCV-related HCC because SHR can prolong life in SVR and BR patients.


Related Articles

  • Interferon Alfacon-1: A Novel Interferon for the Treatment of Chronic Hepatitis C. Alberti, A. // BioDrugs;1999, Vol. 12 Issue 5, p343 

    Interferon alfacon-1 (consensus interferon; CIFN) is a novel, recombinant interferon which has been shown to have greater biological activity in vitro than other interferons. CIFN was tested in a large, phase 3, multicentre, North American study in patients with chronic hepatitis C. Patients...

  • Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course. Arase, Yasuji; Ikeda, Kenji; Chayama, Kazuaki; Murashima, Naoya; Tsubota, Akihito; Suzuki, Yoshiyuki; Saitoh, Satoshi; Kobayashi, Masahiro; Kobayashi, Mariko; Suzuki, Fumitaka; Kumada, Hiromitsu // Journal of Gastroenterology;2000, Vol. 35 Issue 8, p607 

    33Abstract: Some patients with chronic hepatitis C become HCV-RNA seronegative during interferon (IFN) therapy. However, about one-half of these patients show a relapse, evident by high serum alanine aminotransferase (ALT) level. In some patients with biochemical relapse, the serum HCV-RNA level...

  • Factors influencing prognosis after initial inadequate excision (IIE) for soft tissue sarcoma. Van Geel, Albert N.; Eggermont, Alexander M.M.; Hanssen, Patrick E.J.; Schmitz, Paul I.M. // Sarcoma;Sep-Dec2003, Vol. 7 Issue 3/4, p159 

    Purpose . The influence of initial inadequate excision (IIE) of soft tissue sarcoma (STS) on local control and overall survival is not well established. It is generally believed that an IIE may have a negative impact on both, despite subsequent treatment by radical surgery and radiotherapy....

  • Multiple Recurrences of Nonfamilial Cardiac Myxomas. Mendoza, Cesar; Bernstein, Erik; Ferreira, Alexandre // Texas Heart Institute Journal;2007, Vol. 34 Issue 2, p236 

    Cardiac myxomas are the most common primary cardiac tumors. Surgical resection usually provides definitive treatment; however, postoperative tumor recurrence has been reported, especially when myxomas occur as part of a familial pattern. Only a few cases of 2nd recurrence of nonfamilial cardiac...

  • Fourth ventricle rosette-forming glioneuronal tumour in children: an unusual presentation in an 8-year-old patient, discussion and review of the literature. Thurston, Benjamin; Gunny, Roxana; Anderson, Glenn; Paine, Simon; Thompson, Dominic; Jacques, Thomas; Ternier, Jessica // Child's Nervous System;May2013, Vol. 29 Issue 5, p839 

    Introduction: Rosette-forming glioneuronal tumour of the fourth ventricle is a rarely described entity. While usually having an indolent course and hence classified as a WHO grade 1 tumour, the precise characteristics and risk of recurrence of this tumour are still unknown. In addition, the...

  • Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review.  // British Dental Journal;10/14/2006, Vol. 201 Issue 8, p524 

    A study to identify treatment modalities with lowest recurrence rate in treating unicystic ameloblastoma is presented. The recurrence rates were found to be 3.6% for resection, 30.5% for enucleation, 16% for enucleation followed by application of Carnoy solution, and 18% by marsupialization...

  • Resection arthrodesis for giant cell tumors around the knee. Kapoor, Sudhir K.; Tiwari, Akshay // Indian Journal of Orthopaedics;Apr-Jun2007, Vol. 41 Issue 2, p124 

    Background: Giant cell tumors (GCTs) of bone are aggressive benign tumors. Wide resection is reserved for a small subset of patients with biologically more aggressive, recurrent and extensive tumors. As the patients affected with GCT are young or middle-aged adults with a normal life expectancy,...

  • A Rare Case of Undifferentiated Carcinoma of the Colon with Rhabdoid Features: A Case Report and Review of the Literature. Moussaly, E.; Atallah, J. P. // Case Reports in Oncological Medicine;4/30/2015, Vol. 2015, p1 

    Malignant rhabdoid tumors were originally described in children. Subsequently, the same histological pattern was described in adults. Malignant rhabdoid tumors are aggressive neoplasms that have been reported in multiple organs. To our best knowledge, only 16 previous cases of rhabdoid tumor in...

  • Fetal Rhabdomyoma of the Right Tonsil with Polyp-Like Appearance. Wang, Ching-Ping; Chang, Yi-Hao; Chang, Ya-Ting // Case Reports in Otolaryngology;7/13/2015, Vol. 2015, p1 

    Skeletal muscle neoplasms, in contrast to other groups of tumors, are almost malignant. The benign variant, rhabdomyoma, is distinctly rare. Rhabdomyomas can be classified generally into two types: cardiac and extracardiac. Extracardiac rhabdomyoma can be further divided into three subtypes:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics